Ghada Zaytoun
Geriatric Medicine · Selden, NYNPI 1881072932
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Among geriatric medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 157 payments — averaging $23.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$806
- Amgen$580
- Viiv Healthcare Company$320
- Lilly USA, LLC$271
- Novo Nordisk$269
- Abbott$179
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,655100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $806 |
| Amgen | 13 | $580 |
| Viiv Healthcare Company | 5 | $320 |
| Lilly USA, LLC | 10 | $271 |
| Novo Nordisk | 17 | $269 |
| Abbott | 11 | $179 |
| AstraZeneca | 3 | $171 |
| Currax Pharmaceuticals LLC | 10 | $167 |
| Dexcom, Inc. | 2 | $133 |
| Boehringer Ingelheim | 1 | $109 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $90 |
| Xeris Pharmaceuticals, Inc. | 4 | $84 |
| Pfizer | 3 | $65 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $53 |
| Esperion Therapeutics, Inc. | 3 | $46 |
| Actelion Pharmaceuticals US, Inc. | 2 | $43 |
| Merck | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 1 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Novartis | 1 | $24 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| Exact Sciences | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Intuity Medical Inc | 1 | $16 |
| Intra-sana Laboratories | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$250
- APRETUDE$237
- BREZTRI$125
- Otezla$125
- QULIPTA$125
- UBRELVY$125
- DEXCOM G7 GSS (161)$117
- DEXCOM STELO GLUCOSE BIOSENSOR$117
- JARDIANCE$109
How this compares
$3,655 in reported general payments places this provider in the 90th percentile of 400 geriatric medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 11 | $11,425 |
| Rosuvastatin Calcium | 15 | $386 |
| Atorvastatin Calcium | 25 | $251 |
| Tamsulosin Hcl | 11 | $202 |
| Levothyroxine Sodium | 16 | $153 |
| Amlodipine Besylate | 20 | $132 |
| Losartan Potassium | 18 | $122 |
| Gabapentin | 12 | $75 |
| Zolpidem Tartrate | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $271 | $11,42511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 400 geriatric medicine providers in New York.
Other geriatric medicine in Selden
- Wen DombrowskiBrooklyn$45K
- Sharon BrangmanSyracuse$45K
- Howard FillitNew York$42K
- Adam CohenGreat Neck$27K
- Inna ShifrinBrooklyn$21K
- Amit SaxenaBronx$16K
- Nirmala TummalapentaBronx$16K
- Nasem SayeghElmsford$15K
- Bruce LowellGreat Neck$14K
- Andre SerretteHewlett$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.